Florida Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 43 (91% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 20,645
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 62.30%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 2,405
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 61.89%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 33.83% 34.30%
White, Hispanic/Latino Patients 18.50% 16.63%
Black/African American, Non-Hispanic/Latino Patients 26.33% 26.32%
Black/African American, Hispanic/Latino Patients 0.83% 0.58%
Asian Patients3 1.15% 0.58%
American Indian/Alaska Native Patients3 0.56% 0.54%
Native Hawaiian/Other Pacific Islander Patients3 0.30% 0.25%
Patients with More than one race3 3.36% 4.07%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.88% 6.74%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.33% 1.66%
Unreported/Refused to Report Race and Ethnicity 7.94% 8.32%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 3,783
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 83.58%
COVID-19 Immunization Series Completed 4,480
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 82.10%
COVID-19 Immunization Series Additional 1,469
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 49.18%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 15.49% 16.88% 48.60%
White, Hispanic/Latino Patients 29.90% 30.80% 6.40%
Black/African American, Non-Hispanic/Latino Patients 36.82% 33.37% 31.04%
Black/African American, Hispanic/Latino Patients 1.22% 0.98% 1.63%
Asian Patients3 0.77% 0.69% 4.90%
American Indian/Alaska Native Patients3 0.95% 1.76% 0.34%
Native Hawaiian/Other Pacific Islander Patients3 0.40% 0.42% 0.27%
Patients with More than one race3 3.15% 2.83% 2.31%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 5.63% 6.52% 0.14%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.93% 1.70% 0.95%
Unreported/Refused to Report Race and Ethnicity 3.75% 4.04% 3.40%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 25.58%
1 to 24 Hours 18.60%
More Than 24 Hours 55.81%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 9.30%
Staffing to administer the vaccine 30.23%
Vaccine confidence 46.51%
Vaccine storage capacity 2.33%
Vaccine supply 2.33%
Other 4.65%
None 27.91%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 95.35%
Average Percent of Health Center Visits Conducted Virtually 13.60%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 41.86%
Number of Mobile Van Sites 68
Number of Pop-up Clinics 42
Number of School-Based Vaccination Sites 4

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 11.63%
Refer patients to another organization that provides monoclonal antibody therapies 30.23%
None 58.14%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 9.30%
Patient awareness/education 6.98%
Staffing capacity 30.23%
Therapy administration/onsite logistics 16.28%
Other 11.63%
None 41.86%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021